Recent email from Stephen Davis
Please note press release’s recently sent to Pink Sheets and will follow in Newswire shortly
Stephen L Davis
President and CEO
(801) 977-8970 Phone
(801 977-8973 Fax
www.paradigm-medical.com
From: xxxxxxxxxxxxxxxx
Sent: Wednesday, March 03, 2010 3:37 AM
To: Steve Davis
Subject: Shareholder
Importance: High
Mr. Davis,
I am a stockholder in your company and I have been for awhile. I really want to see your company prosper. Whatever happened to the Paravue and what is happening with the Retimax. Please let me know.
Paradigm Medical Announces
SALT LAKE CITY--Paradigm Medical Industries, Inc. (OTC.PK) announced today that
it has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO), that all necessary documents have been completed and submitted to the United States Food and Drug Administration (FDA) for the Retimax™, also known as the Paramax. Paradigm is the exclusive representative for this significant new product in the US market. “This new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm’s glaucoma diagnostic products,” said Stephen Davis, Paradigm’s President and Chief Executive Officer.
The Paramax (as it will be known in the United States) represents the third product that Paradigm represents for CSO. Paradigm also represents CSO’s impressive corneal topographer, to be known in the U.S. as the Paravue 300, and CSO’s corneal topographer with Scheimpflug rotating camera, to be known in the U.S. as the Surveyor 500. The Surveyor 500 with the Scheimpflug camera allows for the complete analysis of the entire cornea and anterior segment of the eye. Paradigm plans to begin active promotion of the Paravue 300 and the Surveyor 500 and will actively promote the Paramax immediately after it has received FDA approval.
About Paradigm Medical Industries, Inc.
Headquartered in Salt Lake City, Utah, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company’s primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Contact:
Paradigm Medical Industries, Inc.
Stephen L. Davis,
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com
For more information, please visit: www.paradigm-medical.com
Paradigm Medical Announces
SALT LAKE CITY--Paradigm Medical Industries, Inc. (OTC.PK) announced today that
the move to its new facility in Salt Lake City, Utah is 95% completed and the manufacture of its medical equipment and devices will begin immediately. President and Chief Executive Officer, Stephen Davis stated: “This move will be the first step in Paradigm returning to normalcy with the manufacture of its medical equipment and devices.”He added: “Our new building is more suitable for our current and future business operations and it will provide an excellent location for manufacturing and product development for years to come.” Paradigm also announced that it will immediately expand both its domestic independent representative sales network and international distributor groups.
About Paradigm Medical Industries, Inc.
Headquartered in Salt Lake City, Utah, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company’s primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Contact:
Paradigm Medical Industries, Inc.
Stephen L. Davis,
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com
For more information, please visit: www.paradigm-medical.com
